Sign In
Buy BVNKF
$27.69
+0 (+0%)
At Close: Jul 31, 2026
Bullish On Bavarian Nordic's Vaccine Portfolio And Revenue Potential In 2025
03:34am, Tuesday, 19'th Nov 2024
Bavarian Nordic holds contracts totaling approximately $340 million for 2025, driven by vaccine demand and global health policies. Its diversified vaccine portfolio targets smallpox, mpox, rabies, tic
Bavarian Nordic's Mpox Moment Fades, But Diversification Shines
11:30am, Sunday, 17'th Nov 2024
Bavarian Nordic's mpox vaccine sales have declined post-outbreak, causing reduced revenue and highlighting its reliance on outbreak-driven demand. The company's Travel Health segment demonstrated stre
Bavarian Nordic A/S (BVNKF) Q3 2024 Earnings Call Transcript
10:39am, Friday, 15'th Nov 2024
Bavarian Nordic A/S (OTCPK:BVNKF) Q3 2024 Earnings Conference Call November 15, 2024 8:00 AM ET Company Participants Rolf Sass Sorensen - VP, IR Paul Chaplin - President and CEO Henrik Juuel - EVP and
Bavarian Nordic CEO says Kennedy nomination could fuel vaccine scepticism
05:40am, Friday, 15'th Nov 2024
Danish biotech Bavarian Nordic anticipates a boost in biodefense funding by the incoming U.S. administration despite concerns that the nomination of Robert F. Kennedy Jr. as health secretary could fue
Bavarian Nordic has $340 mln orders for its mpox, smallpox vaccine in 2025
02:34am, Friday, 15'th Nov 2024
Danish biotech Bavarian Nordic said on Friday the order book for delivery of its vaccine for mpox and smallpox in 2025 currently totals around 2.40 billion crowns ($340 million), including previously
WHO approves Bavarian Nordic's mpox vaccine for adolescents
02:46am, Monday, 14'th Oct 2024
The World Health Organization said on Monday it had approved Bavarian Nordic's mpox vaccine for adolescents aged 12 to 17 years, an age group considered especially vulnerable to outbreaks of the disea
Bavarian Nordic signs agreement with UNICEF for one million mpox vaccines
10:50am, Thursday, 26'th Sep 2024
Bavarian Nordic said on Thursday it has signed an agreement with the UNICEF for one million mpox vaccines, which include 500,000 doses that were committed by the Gavi vaccine alliance.
Bavarian Nordic Upgrades its Financial Guidance for 2024
10:30am, Thursday, 26'th Sep 2024
COPENHAGEN, Denmark, September 26, 2024 – Bavarian Nordic A/S (OMX: BAVA) upgrades its financial guidance for 2024.
Bavarian Nordic Signs Agreement with UNICEF for 1 Million Mpox Vaccines
10:30am, Thursday, 26'th Sep 2024
COPENHAGEN, Denmark, September 26, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced an agreement with UNICEF for the supply of 1 million doses of the MVA-BN® mpox vaccine for countries in Afr
Bavarian Nordic gets $63 million US government order for small pox, mpox vaccine
12:07pm, Tuesday, 24'th Sep 2024
Bavarian Nordic has received an order worth $63 million from the U.S. government to produce additional bulk product and the final freeze-dried doses of its mpox and smallpox vaccine, Jynneos, it said
Bavarian Nordic Awarded USD 63 Million from the U.S. Government for Production and Supply of Additional Smallpox/Mpox Vaccines
11:30am, Tuesday, 24'th Sep 2024
COPENHAGEN, Denmark, September 24, 2024 – Bavarian Nordic A/S (OMX: BAVA) today announced that it has received an additional order valued at USD 63 million from the Biomedical Advanced Research and
Bavarian Nordic Receives EMA Approval of Mpox Vaccine for Adolescents
09:45am, Thursday, 19'th Sep 2024
COPENHAGEN, Denmark, September 19, 2024 – Bavarian Nordic A/S (OMX: BAVA) announced today that the European Commission has adopted the Committee for Medicinal Products for Human Use (CHMP) recommend
Gavi to buy 500,000 mpox vaccine doses from Bavarian Nordic
04:49am, Wednesday, 18'th Sep 2024
The global vaccine group Gavi will buy 500,000 doses of Bavarian Nordic's mpox vaccine, its first purchase of the shot to help battle an outbreak in parts of Africa, the group said on Wednesday.
UK government buys over 150,000 doses of Bavarian Nordic's mpox vaccine
07:17pm, Monday, 16'th Sep 2024
The UK government has ordered more than 150,000 doses of Bavarian Nordic's mpox vaccine to boost its preparedness against a new form of the virus currently spreading in African countries.
WHO clears Bavarian Nordic's vaccine as first shot against mpox
05:52am, Friday, 13'th Sep 2024
The World Health Organization said on Friday it had cleared Bavarian Nordic's vaccine as the first shot against mpox.
